Mar 24, 2023 Inspirational Women in Life Sciences Series - an interview with Lyndsey Hudson By Lyndsey Hudson Mary Foord-Weston In the second of our Cortex series on Inspirational Women in Life Sciences, we are proud to feature DLA Piper’s very own Dr Lyndsey...
Mar 20, 2023 Extended transition period gives medical device industry extra time to comply with EU MDR By Marco de Morpurgo Nicola Landolfi A much-awaited extension of the MDR transition period became effective today with the publication of Regulation (EU) 2023/607 in the...
Mar 17, 2023 FDA calls for comments on artificial intelligence in drug manufacturing By Keo Shaw Bethany Hills Daniel Tobey Geoffrey Levitt +1 more... Show less On March 1, 2023, FDA’s Center for Drug Evaluation and Research (CDER) published a discussion paper on artificial intelligence (AI) in...
Mar 14, 2023 Advertising therapeutic goods in Australia (don't let your ad make you sad) By Nicholas Tyacke Greg Bodulovic Alexandra de Zwart Due to a complex array of legislation, regulations and codes, advertising therapeutic goods in compliance with Australian law can be a...
Mar 10, 2023 Poland - Life Sciences monthly brief, February 2023 By Andrzej Balicki, Ph.D. Jolanta Dabrowicz Przemysław Matuszewski Urszula Grębowska +1 more... Show less Download a copy of our January monthly briefing, which covers key updates and insights in the following areas: Medicinal productsClinical...
Mar 08, 2023 Inspirational women in life sciences series – International Women’s Day By Mary Foord-Weston Beginning on International Women’s Day (IWD), DLA Piper’s Cortex blog is running a series with inspirational guest speakers to celebrate...